- Ziggma
- Posts
- 🗞️ Walmart Surges 6.5%
🗞️ Walmart Surges 6.5%
PLUS: Markets move lower
In partnership with
Market Performance
S&P 500: 6,538.76 ⬇️ 1.56%
Nasdaq: 22,078.05 ⬇️ 2.16%
Dow Jones: 45,752.26 ⬇️ 0.84%
Walmart Powers Through
Walmart (WMT), the retail giant, raised its full-year outlook for the second consecutive quarter after posting impressive fiscal third-quarter results.
Net sales climbed to $179.5 billion, beating analyst expectations of $177.4 billion.
The company now expects full-year sales growth between 4.8% and 5.1%, up from its previous forecast of 3.75% to 4.75%.
A combination of strategic execution and consumer behavior.
Walmart is winning across all income levels as value-seeking shoppers flock to its stores.
E-commerce jumped 27% globally, with U.S. online sales surging 28%.
The company's advertising business exploded by 53%, including its recent Vizio acquisition.
Expedited delivery revenue increased 70% year-over-year as customers prioritize speed and convenience.
About a third of online orders now use one- or three-hour delivery windows.
Walmart stock has a Ziggma score of 47 and ranks lower than most peers in terms of profitability, growth and valuation.
However, the blue-chip stock, which has increased by 430% over the last 10 years, may not offer significant upside potential.
Our Takeaway
Walmart's performance highlights a clear market trend: consumers are consolidating spending with reliable value leaders.
While competitors like Target and Home Depot cut their outlooks, Walmart thrives by executing on all cylinders - competitive pricing, fast delivery, and a growing digital ecosystem.
7 Actionable Ways to Achieve a Comfortable Retirement
Your dream retirement isn’t going to fund itself—that’s what your portfolio is for.
When generating income for a comfortable retirement, there are countless options to weigh. Muni bonds, dividends, REITs, Master Limited Partnerships—each comes with risk and oppor-tunity.
The Definitive Guide to Retirement Income from Fisher investments shows you ways you can position your portfolio to help you maintain or improve your lifestyle in retirement.
It also highlights common mistakes, such as tax mistakes, that can make a substantial differ-ence as you plan your well-deserved future.
Market Overview 📈
Stocks experienced a dramatic intraday reversal on Thursday, wiping out early gains sparked by Nvidia's blockbuster earnings, and closed sharply lower.
The selloff accelerated after a delayed September jobs report showed the economy added 119,000 positions, exceeding the expected 50,000.
This stronger-than-anticipated data dampened hopes for a Federal Reserve rate cut in December.
Fed funds futures now show less than 40% probability of a December cut, down from earlier expectations.
Nvidia's reversal epitomized the market's struggle. Despite reporting better-than-expected quarterly results and strong guidance, shares that initially jumped 5% ultimately closed down 3%.
The broader AI trade rolled over, with the Magnificent Seven all sliding into negative territory.
High-flying names like Palantir and Oracle tumbled 5.5% and nearly 5%, respectively.
The volatility was historic. The Nasdaq traded in a 4.89% intraday range, while the Dow swung over 1,100 points from high to low - its largest range since October.
This marked the biggest reversal for major indices since April, with each experiencing just their second or third such swing in three and a half years.
Defensive sectors provided the only refuge. Consumer staples rose nearly 1%, led by Walmart's 6% surge.
The rotation out of high-valued tech into defensive plays suggests investors are repositioning for a potentially choppier market ahead.
Stock Moves Deciphered 📈
🚀 Regeneron Pharmaceuticals (REGN)
Regeneron gained approximately 4% on November 20, 2025, buoyed by positive analyst sentiment.
Both Wells Fargo and Raymond James raised their price targets for the stock following a strong third-quarter earnings beat and positive pipeline developments, including new FDA approvals.
The upgraded relative strength rating reflects growing investor confidence in the company's biotech portfolio and drug development momentum.
🛁 Bath & Body Works (BBWI)
Bath & Body Works plummeted nearly 25% after missing third-quarter earnings and revenue expectations.
The company slashed its full-year outlook, citing macroeconomic pressures on consumers.
In response, management announced a turnaround plan that includes exiting underperforming categories like haircare and men's grooming to refocus resources on core products.
👀 Jacobs Solutions (J)
Jacobs Solutions saw its stock decline approximately 11% despite reporting strong fiscal fourth-quarter and full-year 2025 earnings.
The drop was likely influenced by broader market weakness and profit-taking following the stock's recent run.
A significant year-over-year decrease in GAAP EPS, attributed to a one-time accounting adjustment rather than operational issues, may have also concerned investors who focused on headline numbers rather than underlying business performance.
Headlines You Can't Miss 👀
₿ Bitcoin briefly dipped to $86,854 - its lowest level since April 21 - amid cascading liquidations of highly leveraged crypto positions.
🏠 Home prices saw their 28th consecutive month of annual gains, with the median existing home price rising 2.1% to $415,200 in October.
☕ Starbucks strike expanded to 95 stores across 65 cities with 2,000 baristas engaged, though the company reports no operational disruptions.
🤝 Walmart acquisition talks - The retailer is in discussions to buy R&A Data, a startup that reduces scams and counterfeits on online marketplaces.
📈 VanEck Semiconductor ETF initially surged 2.3% in premarket trading on Nvidia's results, fueled by gains in AMD and Broadcom, before reversing sharply.
💡 Ray Dalio advised investors not to sell solely due to AI bubble fears, though he cautioned that valuations suggest low returns over the next decade.
Trending Stocks 📊
🤖 Palo Alto Networks (PANW)
Palo Alto Networks shares slipped more than 7% despite narrowly surpassing Wall Street's fiscal first-quarter earnings and revenue expectations.
The company announced it will acquire cloud management company Chronosphere for $3.35 billion.
However, the cybersecurity firm's second-quarter revenue forecast of $2.57-$2.59 billion slightly underwhelmed analysts expecting $2.58 billion.
💉 Insulet Corporation (PODD)
Insulet's stock fell approximately 10% during its investor day presentation.
While the company outlined a positive long-term growth strategy for its diabetes management products, the outlook may not have met investors' more aggressive near-term expectations.
The decline was exacerbated by the broader negative market sentiment that gripped technology and healthcare stocks on November 20.
⬇️ Moderna (MRNA)
Moderna's stock dropped approximately 7.5%, hitting a new 52-week low, despite an initial rally during its Analyst Day.
The biotech company outlined a three-year strategic plan with ambitious long-term growth targets.
However, concerns about near-term revenue forecasts and the broader market downturn overshadowed the positive long-term outlook, with investors prioritizing immediate performance over future potential.
What’s Next?
Key market and macro news 👇
📊 The release of the Manufacturing and Services Purchasing Managers' Indexes (PMI) will provide key insights into the health of these vital sectors of the U.S. economy.
🏦 Speeches from Federal Open Market Committee (FOMC) members could offer insights into future monetary policy.
💸 The release of the federal budget balance will show the difference between the federal government's income and spending, which can impact investor confidence.
🏠 Housing Starts: This data on new residential construction activity can signal the health of the housing market and broader economy.
💰 Nvidia's Influence: Following its recent earnings report, Nvidia's performance will remain a key indicator for the AI sector and the broader tech market.
Chart of the Day
Source: App Economy Inisghts
Meme of the Day
Great investing starts with great information.
Forward The Market Scoop to anyone who wants to stay ahead of the market through a pertinent and entertaining newsletter format.
DISCLAIMER: None of this is financial advice. The newsletter is strictly educational and is not investment advice or a solicitation to buy or sell assets or make financial decisions. Please exercise caution and conduct your own research.